1. CymaBay Announces the Appointment of Dr. Evan Stein, M.D., Ph.D., to its Board of Directors

    CymaBay Announces the Appointment of Dr. Evan Stein, M.D., Ph.D., to its Board of Directors

    CymaBay Therapeutics, Inc., today announced the appointment of Dr. Evan Stein, M.D., Ph.D., to the company’ s Board of Directors effective April 1, 2016.. Stein is a world ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. Dr. Stein is a world renowned expert in the area of lipid metabolism with a particular focus during his distinguished career on the development of therapies to treat familial hypercholesterolemia.
    2. I am very excited about joining the Board of Directors of CymaBay Therapeutics. I am particularly intrigued by MBX-8025, the company's potent and selective PPAR-δ agonist, which represents a potential new approach to treating familial hypercholesterolemia and other lipid disorders.
  3. Topics Mentioned